OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 48 filers reported holding OVID THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,523 | -22.3% | 13,157 | -33.7% | 0.00% | – |
Q2 2023 | $65,059 | -77.5% | 19,835 | -72.4% | 0.00% | – |
Q1 2021 | $289,000 | +74.1% | 71,956 | 0.0% | 0.00% | – |
Q4 2020 | $166,000 | -55.4% | 71,956 | +11.1% | 0.00% | -100.0% |
Q3 2020 | $372,000 | -21.8% | 64,757 | +0.3% | 0.00% | 0.0% |
Q2 2020 | $476,000 | +1222.2% | 64,550 | +220.2% | 0.00% | – |
Q1 2019 | $36,000 | -26.5% | 20,162 | 0.0% | 0.00% | – |
Q4 2018 | $49,000 | -57.0% | 20,162 | 0.0% | 0.00% | – |
Q3 2018 | $114,000 | -27.4% | 20,162 | 0.0% | 0.00% | – |
Q2 2018 | $157,000 | +18.9% | 20,162 | +8.0% | 0.00% | – |
Q1 2018 | $132,000 | +50.0% | 18,676 | +109.8% | 0.00% | – |
Q4 2017 | $88,000 | +15.8% | 8,900 | 0.0% | 0.00% | – |
Q3 2017 | $76,000 | -18.3% | 8,900 | 0.0% | 0.00% | – |
Q2 2017 | $93,000 | – | 8,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 1,319,679 | $4,329 | 18.57% |
Madison Avenue Partners, LP | 3,307,605 | $10,848,943 | 2.37% |
CHI Advisors LLC | 864,822 | $2,836,616 | 0.86% |
Rubric Capital Management LP | 5,445,910 | $17,862,585 | 0.76% |
BVF INC/IL | 6,851,051 | $22,471,447 | 0.63% |
EcoR1 Capital, LLC | 6,117,400 | $20,065,072 | 0.49% |
Artal Group S.A. | 2,500,000 | $8,200 | 0.25% |
Tejara Capital Ltd | 112,591 | $369,298 | 0.18% |
DCF Advisers, LLC | 64,764 | $212,426 | 0.11% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 801,152 | $2,627,779 | 0.06% |